TCW Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,981
| Closed | -$2.58M | – | 362 |
|
|
2021
Q1 | $2.58M | Buy |
11,981
+6
| +0.1% | +$1.29K | 0.02% | 241 |
|
|
2020
Q4 | $2.83M | Buy |
+11,975
| New | +$2.83M | 0.02% | 226 |
|
|
2017
Q1 | – | Sell |
-25,035
| Closed | -$1.84M | – | 615 |
|
|
2016
Q4 | $1.84M | Hold |
25,035
| – | – | 0.01% | 370 |
|
|
2016
Q3 | $2.18M | Sell |
25,035
-1,608
| -6% | -$140K | 0.02% | 312 |
|
|
2016
Q2 | $2.29M | Buy |
26,643
+750
| +3% | +$64.5K | 0.02% | 299 |
|
|
2016
Q1 | $2.06M | Sell |
25,893
-320
| -1% | -$25.4K | 0.02% | 331 |
|
|
2015
Q4 | $3.3M | Buy |
26,213
+670
| +3% | +$84.3K | 0.02% | 259 |
|
|
2015
Q3 | $2.66M | Sell |
25,543
-2,250
| -8% | -$234K | 0.02% | 292 |
|
|
2015
Q2 | $3.43M | Sell |
27,793
-51,711
| -65% | -$6.39M | 0.02% | 294 |
|
|
2015
Q1 | $9.38M | Buy |
79,504
+2,361
| +3% | +$279K | 0.05% | 261 |
|
|
2014
Q4 | $9.17M | Sell |
77,143
-48,350
| -39% | -$5.74M | 0.04% | 279 |
|
|
2014
Q3 | $14.1M | Sell |
125,493
-1,750
| -1% | -$197K | 0.06% | 259 |
|
|
2014
Q2 | $12M | Buy |
127,243
+3,900
| +3% | +$369K | 0.05% | 301 |
|
|
2014
Q1 | $8.72M | Sell |
123,343
-4,800
| -4% | -$339K | 0.04% | 359 |
|
|
2013
Q4 | $9.52M | Buy |
128,143
+245
| +0.2% | +$18.2K | 0.04% | 340 |
|
|
2013
Q3 | $9.7M | Buy |
127,898
+114,925
| +886% | +$8.71M | 0.04% | 316 |
|
|
2013
Q2 | $1.04M | Buy |
+12,973
| New | +$1.04M | 0.01% | 677 |
|